Forsythiaside A Activates AMP-Activated Protein Kinase and Regulates Oxidative Stress via Nrf2 Signaling
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242317033 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Young Eun Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: AI-Bio Convergence DDI Basic Research Lab., School of Korean Medicine, Dongguk University, Gyeongju 38066, Republic of Korea. Hauptthemen laut MEDLINE: AMP-Activated Protein Kinases, Antioxidants. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), Ministry of Health and Welfare, Republic of Korea.
Abstract (Originalsprache)
Forsythiaside A (FA) is an active constituent isolated from Forsythia suspensa, a beneficial herb used in traditional medicine known for its antioxidant and anti-inflammatory properties. Although various studies have suggested that FA has the protective effects, its impacts on arachidonic acid (AA) plus iron in vitro models and carbon tetrachloride (CCl₄)-induced mouse liver damage in vivo have not been explored. In this study, HepG2 cells were subjected to AA + iron treatment to induce apoptosis and mitochondrial impairment and determine the molecular mechanisms. FA exhibited protective effects by inhibiting cell damage and reactive oxygen species (ROS) production induced by AA + iron, as assessed via immunoblot and flow cytometry analyses. Further molecular investigations revealed that FA resulted in the activation of extracellular-signal-related protein kinase (ERK), which subsequently triggered the activation of AMP-activated protein kinase (AMPK), a critical regulator of cellular oxidative stress. Additionally, FA modulated the nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathway, which is a significant antioxidant transcription factor regulated by the AMPK pathway. For in vivo studies, mice were orally administered FA and then subjected to induction of CCl₄-based hepatotoxicity. The protective effect of FA was confirmed via blood biochemistry and immunohistochemical analyses. In conclusion, our findings demonstrated the protective effects of FA against oxidative stress both in vitro and in vivo, thus indicating that FA is a potential candidate for liver protection. Our study sheds light on the mechanistic pathways involved in the antioxidant effects of FA, highlighting the hepatoprotective potential of naturally occurring compounds in traditional herbs, such as FA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- AI-Bio Convergence DDI Basic Research Lab., School of Korean Medicine, Dongguk University, Gyeongju 38066, Republic of Korea.
- College of Korean Medicine, Wonkwang University, Iksan 54538, Republic of Korea.
ORCID-Profile: Su-Jin Bae, Young Woo Kim
Förderung
- Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI)
- Ministry of Health and Welfare, Republic of Korea
Zitieren
APA
Kim, Y. E., Bak, S. B., Kim, M. J., Bae, S. J., Lee, W. Y., & Kim, Y. W. (2023). Forsythiaside A Activates AMP-Activated Protein Kinase and Regulates Oxidative Stress via Nrf2 Signaling. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242317033
Vancouver
Kim YE, Bak SB, Kim MJ, Bae SJ, Lee WY, Kim YW. Forsythiaside A Activates AMP-Activated Protein Kinase and Regulates Oxidative Stress via Nrf2 Signaling. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242317033
BibTeX
@article{Kim2023,
author = {Kim, Young Eun and Bak, Seon-Been and Kim, Min-Jin and Bae, Su-Jin and Lee, Won-Yung and Kim, Young Woo},
title = {Forsythiaside A Activates AMP-Activated Protein Kinase and Regulates Oxidative Stress via Nrf2 Signaling},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242317033}
}
EUVIMED